Fiera Capital (Canada)’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.6M | Buy |
530,683
+1,241
| +0.2% | +$38.8K | 0.06% | 164 |
|
2025
Q1 | $17.8M | Sell |
529,442
-6,445
| -1% | -$216K | 0.06% | 162 |
|
2024
Q4 | $21M | Sell |
535,887
-18,313
| -3% | -$718K | 0.07% | 147 |
|
2024
Q3 | $21.8M | Sell |
554,200
-28,679
| -5% | -$1.13M | 0.07% | 150 |
|
2024
Q2 | $22.7M | Buy |
582,879
+6,337
| +1% | +$247K | 0.07% | 141 |
|
2024
Q1 | $24.8M | Buy |
576,542
+23,512
| +4% | +$1.01M | 0.07% | 140 |
|
2023
Q4 | $25.5M | Sell |
553,030
-7,516
| -1% | -$346K | 0.08% | 137 |
|
2023
Q3 | $19.1M | Buy |
560,546
+11,205
| +2% | +$383K | 0.06% | 151 |
|
2023
Q2 | $21.1M | Buy |
+549,341
| New | +$21.1M | 0.06% | 144 |
|